Tags : Supply

Pfizer Signs a License and Supply Agreement with ImaginAb for

Tuba Khan January 7, 2021

Shots: ImaginAb to receive license fees and payments for manufacturing and other support and will supply clinical doses of 89Zr CD8 Immuno-PET agent to Pfizer for use in select oncology clinical trials ImaginAb will provide technical, clinical & regulatory support to Pfizer The collaboration follows the pre-competitive alliance b/w ImaginAb, Pfizer and other global companies […]Read More

COVID-19 Regulatory

AstraZeneca’s AZD1222 Receives MHRA’s Emergency Supply Authorization in the UK

Tuba Khan December 30, 2020

Shots: The MHRA has provided authorization for an emergency supply of AZD1222, for the active immunization of individuals aged ≥18yrs. The approval recommends 2 doses administered with an interval of between 4 & 12wks The authorization is based on independent advice from its CHM following a rolling review of trial data that included an interim […]Read More

Clinical Trials

Pfizer and BioNTech to Supply EU with up to 200M

Tuba Khan November 12, 2020

Shots: The companies sign an agreement with the EC to supply 200M doses of BNT162b2 mRNA-based vaccine candidate against SARS-CoV-2 to EU member states, with an option to request an additional 100M doses Deliveries are anticipated to start by the end of 2020, following clinical success and regulatory authorization. The companies expect to produce ~1.3B […]Read More

Biotech COVID-19

Novavax Collaborates with Commonwealth of Australia to Supply 40M doses

Tuba Khan November 5, 2020

Shots: Novavax has signed a non-binding Heads of Terms document with the Australian Government to supply 40M doses of NVX-CoV2373 for the Australian community The delivery will start as early as H1’21, following the completion of P-III study and the TGA’s approval of the vaccine. The vaccine regimen is expected to require two doses per […]Read More

Pharma

IDEAYA and Pfizer Expand CTC and Supply Agreement for Solid

Tuba Khan September 24, 2020

Shots: The companies have expanded their clinical trial collaboration and supply agreement for IDE196 and crizotinib. The study will evaluate combination therapy in patients with solid tumors having GNAQ or GNA11 mutations (GNAQ/11), including MUM, skin melanoma, lung cancer, and colorectal cancer The two global companies have established JDC and there will be joint decision […]Read More

Biotech COVID-19

Pfizer and BioNTech to Supply 200M Doses of it COVID-19

Tuba Khan September 10, 2020

Shots: Pfizer and BioNTech has concluded exploratory talks with the EC for a proposed supply of 200M doses of BNT162 mRNA-based vaccine candidate against COVID-19 to EU, with an option for further 100M doses, expected delivery to be started by the end of 2020 The proposed agreement with the EC represents the largest initial order […]Read More

Biotech COVID-19

Johnson & Johnson Collaborates with the Government of Canada to

Tuba Khan September 1, 2020

Shots: Janssen signs an agreement in principle with the Government of Canada to supply its COVID-19 vaccine, ensuring broad Canadian access to Ad26.COV2.S, following Health Canada’s approval In addition, a final agreement will be determined in due course under which the Government of Canada would purchase ~38M doses of Janssen’s vaccine candidate on a not-for-profit […]Read More

Biotech

BioNTech and Fosun Pharma to Supply ~10M Doses of COVID-19

Tuba Khan August 28, 2020

Shots: BioNTech and Fosun collaborated to supply 10M doses of their BNT162 mRNA-based vaccine candidate against COVID-19 to Hong Kong SAR and Macao SAR, once approved Fosun Pharma has signed the Letter of Intent with Jacobson for contemplated distribution of 10M doses of a vaccine targeting COVID-19 in the Chinese market On Mar 13, 2020, […]Read More

Biosimilars

BeiGene Signs a License and Supply Agreement with Bio-Thera for

Tuba Khan August 25, 2020

Shots: Bio-Thera to receive $165M upfront, regulatory, and commercial milestones and is eligible to receive royalties on sales of the product. BeiGene to get the right to develop, manufacture, and commercialize BAT1706 in China, including Hong Kong, Macau, and Taiwan while Bio-Thera will retain rights for the therapy outside the licensed territory The NMPA has […]Read More

Biotech COVID-19

Novavax Collaborates with UK Government to Supply 60M Doses of

Tuba Khan August 14, 2020

Shots: Novavax will supply ~60M doses of its COVID-19 vaccine to the UK government for P-III study evaluating the efficacy of NVX-CoV2373 in ~9,000 adults aged 18-85yrs. in the UK. The trial is expected to initiate in Q3’20 Novavax will expand its collaboration with FUJIFILM Diosynth, which will manufacture the antigen component of NVX-CoV2373 from […]Read More

Amgen Collaborates with Evoq to Develop Novel Therapies for Autoimmune Disorders

Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

Janssen Signs a Research Agreement with TenNor to Develop Treatments for Nontuberculous Mycobacteria Diseases

Boehringer Ingelheim Collaborates with Cure Genetics to Develop Next-Generation Liver-Targeted Gene Therapy

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Henlius’ HLX15 (biosimilar, daratumumab) Receives IND Approval for Multiple Myeloma in China

Celltrion Report Results of CT-P59 in P-II/III Study for COVID-19

The US Government to Purchase Additional Doses of Regeneron’s Casirivimab and Imdevimab to Combat COVID-19

Tessa’s CD30 CAR-T Therapy Receives EMA’s PRIME Designation for Relapsed or Refractory Classical Hodgkin Lymphoma

Genmab’s Darzalex Faspro (daratumumab and hyaluronidase-fihj) Receives the US FDA’s Approval for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Nanobiotix Presents Results of NBTXR3 (PEP503) in P-Ib/II Study for Rectal Cancer at ASCO-GI 2021

Tags : Supply

Pfizer Signs a License and Supply Agreement with ImaginAb for

AstraZeneca’s AZD1222 Receives MHRA’s Emergency Supply Authorization in the UK

Pfizer and BioNTech to Supply EU with up to 200M

Novavax Collaborates with Commonwealth of Australia to Supply 40M doses

IDEAYA and Pfizer Expand CTC and Supply Agreement for Solid

Pfizer and BioNTech to Supply 200M Doses of it COVID-19

Johnson & Johnson Collaborates with the Government of Canada to

BioNTech and Fosun Pharma to Supply ~10M Doses of COVID-19

BeiGene Signs a License and Supply Agreement with Bio-Thera for

Novavax Collaborates with UK Government to Supply 60M Doses of

Latest Posts

ViewPoints Interview: Kaia Health’s Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App

Philips to Acquire Capsule Technologies for ~$635M

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Tags : Supply

Latest Posts

Categories

Related Topics